Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2.

Gewurz BE, Gaudet R, Tortorella D, Wang EW, Ploegh HL, Wiley DC.

Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6794-9.

2.
3.

Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation.

Barel MT, Ressing M, Pizzato N, van Leeuwen D, Le Bouteiller P, Lenfant F, Wiertz EJ.

J Immunol. 2003 Dec 15;171(12):6757-65.

4.
5.

Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation.

Chevalier MS, Daniels GM, Johnson DC.

J Virol. 2002 Aug;76(16):8265-75. Erratum in: J Virol 2002 Dec;76(24):13126.

6.

Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.

Johnson DC, Hegde NR.

Curr Top Microbiol Immunol. 2002;269:101-15. Review.

PMID:
12224504
7.

Human cytomegalovirus (HCMV) US2 protein interacts with human CD1d (hCD1d) and down-regulates invariant NKT (iNKT) cell activity.

Han J, Rho SB, Lee JY, Bae J, Park SH, Lee SJ, Lee SY, Ahn C, Kim JY, Chun T.

Mol Cells. 2013 Nov;36(5):455-64. doi: 10.1007/s10059-013-0221-8. Epub 2013 Nov 8.

8.

Cyclophilin C Participates in the US2-Mediated Degradation of Major Histocompatibility Complex Class I Molecules.

Chapman DC, Stocki P, Williams DB.

PLoS One. 2015 Dec 21;10(12):e0145458. doi: 10.1371/journal.pone.0145458. eCollection 2015.

9.
10.
11.

Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation.

Barel MT, Pizzato N, Le Bouteiller P, Wiertz EJ, Lenfant F.

Int Immunol. 2006 Jan;18(1):173-82. Epub 2005 Dec 16.

PMID:
16361314
12.
14.
15.

A single viral protein HCMV US2 affects antigen presentation and intracellular iron homeostasis by degradation of classical HLA class I and HFE molecules.

Vahdati-Ben Arieh S, Laham N, Schechter C, Yewdell JW, Coligan JE, Ehrlich R.

Blood. 2003 Apr 1;101(7):2858-64. Epub 2002 Nov 27.

16.

The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP.

Ahn K, Gruhler A, Galocha B, Jones TR, Wiertz EJ, Ploegh HL, Peterson PA, Yang Y, Früh K.

Immunity. 1997 May;6(5):613-21.

17.

A structural determinant of human cytomegalovirus US2 dictates the down-regulation of class I major histocompatibility molecules.

Oresic K, Noriega V, Andrews L, Tortorella D.

J Biol Chem. 2006 Jul 14;281(28):19395-406. Epub 2006 May 10.

18.

Differential down-modulation of HLA-G and HLA-A2 or -A3 cell surface expression following human cytomegalovirus infection.

Pizzato N, Garmy-Susini B, Le Bouteiller P, Lenfant F.

J Reprod Immunol. 2004 Jun;62(1-2):3-15.

PMID:
15288176
19.

Signal peptide peptidase is required for dislocation from the endoplasmic reticulum.

Loureiro J, Lilley BN, Spooner E, Noriega V, Tortorella D, Ploegh HL.

Nature. 2006 Jun 15;441(7095):894-7. Epub 2006 May 31.

PMID:
16738546
20.

Supplemental Content

Support Center